SEC Filings

Filing	Description	Date Filed	Size
10-Q	quarterly report	Aug 6, 2010	275.5 KB
8-K	current report	Aug 5, 2010	98.9 KB
SC 13G/A	amended statement of beneficial ownership	Jul 9, 2010	23.3 KB
4	graziano, chane	Jun 8, 2010	19.1 KB
4	green, david	Jun 8, 2010	19.0 KB
4	luscinski, susan m	Jun 8, 2010	17.6 KB
4	mcnaughton, thomas	Jun 8, 2010	19.1 KB
4	dishman, robert a	Jun 8, 2010	18.9 KB
4	harte, neal j	Jun 8, 2010	18.9 KB
4	kennedy, john f	Jun 8, 2010	19.2 KB
4	lewis, earl r	Jun 8, 2010	19.0 KB
4	uveges, george	Jun 8, 2010	19.0 KB
SC 13G	statement of beneficial ownership	Jun 3, 2010	41.7 KB
8-K	current report	Jun 3, 2010	83.6 KB
8-K	current report	Jun 2, 2010	21.0 KB
10-Q	quarterly report	May 7, 2010	221.6 KB
8-K	current report	Apr 29, 2010	83.1 KB
DEF 14A	definitive proxy statement	Apr 23, 2010	347.8 KB
8-K	current report	Apr 23, 2010	56.2 KB
10-K	annual report	Mar 11, 2010	909.3 KB
Showing 1-20 of 419 Page: 1 2 3 ... 21  Next 20

Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.